Company News
December 24, 2020
Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc.
Vancouver, British Columbia, Canada – December 24, 2020 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A14XHT) (the “Company”) is pleased to announce...
Read more
Company News
December 03, 2020
Core One Labs Announces Resumption of Trading
Vancouver, British Columbia, Canada – December 2, 2020 – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) (the “Company”)...
Read more
Company News
November 01, 2020
Core One Labs Provides Update on Financial Statements and Management Cease Trade Order
Vancouver, British Columbia, Canada – July 15, 2020 – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABD), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”). The Company wishes...
Read more
Company News
October 30, 2020
Core One Labs Signs Letter of Intent to Sell Certain Assets
Vancouver, British Columbia, Canada – October 30, 2020 – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABD), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
October 07, 2020
Core One Labs Signs Letter of Intent to Acquire Vocan Biotechnologies
Vancouver, British Columbia, Canada – October 7, 2020 – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABD), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
September 29, 2020
Core One Labs Announces Anticipated Release Date of 2020 Second Quarter Results
Vancouver, British Columbia, Canada – September 29, 2020 – Core One Labs Inc. (CSE: COOL), (OTCQX: CLABD), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) announces that...
Read more
12